- ►duanessolution.com S Biester, C Deuter, H Michels, R Haefner, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: We retrospectively analysed 18 patients, who were treated with
Adalimumab (20–40 mg, every 2 weeks, when ineffective every week); 17 had
juvenile idiopathic arthritis, one was without detectable underlying ... Cited by 76 - Related articles - BL Direct - All 5 versions
- ►cornellpediatrics.org [PDF] LB Vazquez-Cobian, T Flynn, TJA Lehman - The Journal of pediatrics, 2006 - Elsevier Adalimumab is a recombinant human immunoglobulin G1 monoclonal antibody that
binds specifically to TNFα and blocks interaction with the p55 and p75 cell
surface receptors. We hypothesized that this monoclonal antibody would be ... Cited by 54 - Related articles - All 18 versions
P Tynjala, P Lindahl, V Honkanen, P … - British Medical Journal, 2007 - ard.bmj.com Results: Of the 45 patients, uveitis improved in 14 (31%), no change was
observed in 14 (31%) and the activity of uveitis increased in 17 (38%).
Inflammatory activity improved more frequently (p = 0.047) in the patients ... Cited by 43 - Related articles - BL Direct - All 6 versions
JA Smith, DJS Thompson, SM Whitcup, E … - Arthritis and Rheumatism-Arthritis Care and Research, 2005 - sepeap.es Objective. To investigate the safety and efficacy of etanercept in the treatment
of uveitis associated with juvenile idiopathic arthritis (JIA). Methods.
Children who met the American College of Rheumatology diagnostic criteria ... Cited by 86 - Related articles - View as HTML - All 6 versions
JC Richards, ML Tay-Kearney, K Murray, P … - Clinical &# 38; Experimental Ophthalmology, 2005 - ingentaconnect.com Infliximab may be a useful adjunct to the management of refractory juvenile
idiopathic arthritis-associated uveitis. In our series it was associated with
improved uveitis control and simplification of drug use as well as possibly ... Cited by 51 - Related articles - BL Direct - All 2 versions
P Kahn, M Weiss, LF Imundo, DM Levy - Ophthalmology, 2006 - Elsevier Uveitis in children most commonly is associated with juvenile idiopathic
arthritis. In addition to topical glucocorticoids, treatment may include
systemic immunosuppressive agents. Tumor necrosis factor α (TNF-α) has ... Cited by 47 - Related articles - All 11 versions
- ►unizh.ch [PDF] RK Saurenmann, AV Levin, BM Feldman, RM … - The Journal of pediatrics, 2006 - Elsevier We identified 70 patients treated with anti-TNFα without a prior diagnosis of
uveitis. Two of these 70 patients (2.9%), both treated with etanercept, had
development of new-onset uveitis during anti-TNFα therapy. One had ... Cited by 21 - Related articles - All 18 versions
B Mushtaq, T Saeed, RD Situnayake, PI … - Eye (London, England), 2007 - ncbi.nlm.nih.gov AIMS: To describe the clinical outcome of three patients with Behçet's disease
maintained on infliximab who were switched to adalimumab therapy. METHODS: Case
note review. Main outcome measure was recurrence of uveitis. RESULTS: All ... Cited by 38 - Related articles - BL Direct - All 4 versions
SP Ardoin, D Kredich, E Rabinovich, LE … - American Journal of Ophthalmology, 2007 - Elsevier Of sixteen children (29 affected eyes) with median age 11 years, six had
associated extraocular inflammatory conditions. Fifteen of 16 were treated with
concomitant methotrexate. Median follow-up was 26 months and median ... Cited by 19 - Related articles - All 25 versions
